---
title: "Novo and Hims resolve dispute, will sell obesity drugs together, Bloomberg News reports"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278185211.md"
datetime: "2026-03-07T00:56:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278185211.md)
  - [en](https://longbridge.com/en/news/278185211.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278185211.md)
---

# Novo and Hims resolve dispute, will sell obesity drugs together, Bloomberg News reports

March 6 (Reuters) - Wegovy maker Novo Nordisk (NOVOb.CO) plans to sell its weight-loss drugs on Hims & Hers Health (HIMS.N) platform, bringing an end to a dispute between the two companies that escalated into a legal battle last month, Bloomberg News reported on Friday.

Novo and Hims plan to announce a new partnership as soon as Monday, the report said, citing a person familiar with the matter.

### Related Stocks

- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [HIMY.US](https://longbridge.com/en/quote/HIMY.US.md)
- [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md)
- [NVOX.US](https://longbridge.com/en/quote/NVOX.US.md)
- [HIMZ.US](https://longbridge.com/en/quote/HIMZ.US.md)

## Related News & Research

- [BREAKINGVIEWS-Weight loss drugs face first economic stress test](https://longbridge.com/en/news/282631128.md)
- [Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development](https://longbridge.com/en/news/282636425.md)
- [Novo Nordisk (0QIU) Receives a Hold from Jefferies](https://longbridge.com/en/news/282799060.md)
- [Novo Nordisk Expands Workforce After Deep Cuts](https://longbridge.com/en/news/283036289.md)
- [Novo Nordisk's stock rallies after drugmaker reveals deal with OpenAI](https://longbridge.com/en/news/282698267.md)